Small-cell lung cancer (SCLC) is an aggressive cancer with limited treatment options. Nearly all cases show deregulation in cell cycle progression, a therapeutic vulnerability that can be exploited.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback